IDEXX Laboratories (NASDAQ:IDXX – Get Free Report) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided EPS guidance of 10.370-10.530 for the period, compared to the consensus EPS estimate of 10.520. The company issued revenue guidance of $3.9 billion-$3.9 billion, compared to the consensus revenue estimate of $3.9 billion.
IDEXX Laboratories Price Performance
Shares of IDXX stock opened at $451.08 on Thursday. The firm’s 50-day moving average is $481.87 and its two-hundred day moving average is $488.22. The company has a market capitalization of $37.25 billion, a PE ratio of 43.67, a price-to-earnings-growth ratio of 4.03 and a beta of 1.33. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.37 and a quick ratio of 1.03. IDEXX Laboratories has a 12 month low of $372.50 and a 12 month high of $583.39.
IDEXX Laboratories (NASDAQ:IDXX – Get Free Report) last posted its earnings results on Tuesday, August 6th. The company reported $2.44 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.88 by ($0.44). IDEXX Laboratories had a return on equity of 57.03% and a net margin of 22.34%. The business had revenue of $1 billion for the quarter, compared to analyst estimates of $1.01 billion. During the same period last year, the business earned $2.67 EPS. IDEXX Laboratories’s revenue was up 6.4% compared to the same quarter last year. Analysts predict that IDEXX Laboratories will post 10.44 earnings per share for the current year.
Analyst Upgrades and Downgrades
Read Our Latest Research Report on IDXX
IDEXX Laboratories Company Profile
IDEXX Laboratories, Inc develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy.
Featured Articles
- Five stocks we like better than IDEXX Laboratories
- What Are Some of the Best Large-Cap Stocks to Buy?
- Chipotle Serves Up a Price Dip – The Market Is Buying
- Learn Technical Analysis Skills to Master the Stock Market
- Bitcoin Breakout: 3 Stocks Set to Ride the Cryptocurrency Wave
- Market Cap Calculator: How to Calculate Market Cap
- Charging Ahead: Investing in the EV Charging Infrastructure
Receive News & Ratings for IDEXX Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEXX Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.